Case Delays Are Costly: The OR Disruption Nobody Talks About

It starts as a routine morning. The OR schedule is set, the team is prepped, and medications have already been pulled for the first few cases of the day. Then, fifteen minutes before the first patient is supposed to arrive, a prior authorization comes back denied. The case is postponed. 

The surgeon's office is scrambling to sort out next steps. Meanwhile, your clinical team is left trying to reconcile prepared medications, incomplete documentation, and a workflow that suddenly no longer matches the schedule on the board. 

This scenario is happening more frequently across ambulatory surgery centers. And while the patient care side of prior authorization delays gets most of the attention, there's another layer that doesn't get talked about as much: what happens to the medications and controlled substances that were already in motion when the case changed. 

The Schedule Has Less Margin Than It Used To 

Prior authorization requirements have expanded to cover more procedure types, and approvals that once felt predictable now routinely aren't. Cases that seemed confirmed days in advance get flagged, delayed, or pulled from the schedule with very little notice. 

At the same time, ASC volumes keep growing. More complex procedures are moving into the outpatient setting, turnover expectations are tight, and teams are being asked to move faster with fewer people. When a case gets pushed or canceled, the rest of the schedule doesn't pause to accommodate it. The rooms are still turning, other patients are still arriving, and someone has to make quick decisions about medications that were already in motion. 

The Medications Are Already in Motion 

Here's the part of this problem that tends to get overlooked. By the time a case delay reaches the clinical team, medications may already be well into the preparation process. A controlled substance may have been pulled from the automated dispensing cabinet. Syringes may have been drawn up and labeled. Documentation may have been started but not yet completed in the EMR. 

The delay doesn't undo any of that. It creates a gap between what was documented, what was prepared, and what actually happened during the case - which, in some situations, means nothing happened at all because the case never started. 

Controlled substances require a documented chain of custody from dispensing through administration or waste. When a case is canceled before a medication reaches its intended endpoint, that chain still needs to be closed out accurately. Waste needs to be witnessed and documented. Returns need to be recorded. If a medication was prepared but never administered, that fact needs to be clearly captured and tied to the right patient record and case status. 

On a normal day, those steps are part of a practiced workflow. When a case is disrupted unexpectedly, they have to happen while the team is simultaneously managing schedule changes, communicating with the surgeon's office, and keeping the rest of the day moving. 

Where Manual Workflows Start to Break Down 

Manual documentation processes work reasonably well when the day goes as planned. Disruptions are where the gaps tend to appear. 

A staff member who intended to document waste before moving to the next room gets called to help with a turnover that's running behind. A notation that should have been made at the time of cancellation gets entered later from memory, or not at all. A return that needed a witness signature gets delayed because the charge nurse is managing two other things across two other rooms. 

It's what happens when a process wasn't designed for interruption. And those small gaps in documentation can become larger problems during accreditation surveys, DEA reviews, or audits. Controlled substance accountability is an area where reviewers look closely, and inconsistencies in timing or chain of custody stand out - even when the underlying facts are completely straightforward. 

Smaller teams mean fewer people available to catch those gaps in real time. And documentation requirements across ASC operations have only grown more demanding over time. 

What the Team Actually Needs 

When a disruption hits, the clinical team needs to quickly see what's been pulled, what's been prepared, and what still needs to be reconciled. Without that visibility, getting everything back into an accurate state becomes a manual cleanup project: someone tracing back through partial records, asking staff who have already moved on to other rooms, trying to reconstruct a complete picture after the fact. 

That kind of reactive reconciliation takes time that most ASC teams don't have in the middle of an active OR schedule. 

MedServe gives clinical teams real-time visibility into controlled substance movement - what's been pulled, what's been prepared, and what still needs to be closed out - so a canceled case doesn't turn into a documentation recovery project. The chain of custody stays intact without adding more steps to a team that's already moving fast. 

Built for the Day That Didn't Go as Planned 

Most medication accountability workflows were built around the assumption that the schedule holds. The more that assumption breaks down, the more those processes start to show their limits. 

The gaps that show up in controlled substance documentation during disruptions usually aren't the result of poor practice. They're the result of a workflow that wasn't built to handle the unexpected. Closing everything out gets harder when it relies on the right person being in the right place at the right time, every time. 

Most ASC teams dealing with this just need processes that hold up when the schedule doesn't. If that sounds familiar, let's find some time to talk.